Peter Hofland, PhD's Blog Posts Tagged 'care' (30)

UK Charity Calls for More Attention and Awareness for Bladder Cancer

Data from various cancer registries in the United Kingdom shows that Bladder Cancer is a common cancer among men and women in the United Kingdom, with 10.335 new cases diagnosed in 2008. [1][2][3][4] It is one of the most frequently diagnosed cancer of the urinary system and accounts for 1 in every 30 new cases. With 7,390 new cases diagnosed in 2008, is a the 4th most common cancer in men [5] and 11th in women (2,945 female cases), giving a male: female ration of…

Continue

Added by Peter Hofland, PhD on May 7, 2013 at 9:30pm — No Comments

Unique Partnership will Help Oncologists Support Cancer Patients with Evidence-based Palliative Care

The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing physicians who care for people with cancer, and the American Academy of Hospice and Palliative Care Medicine (AAHPM), an organization representing physicians and healthcare professionals committed to improving the care of patients with serious or life-threatening conditions, earlier…

Continue

Added by Peter Hofland, PhD on March 6, 2013 at 10:00pm — No Comments

A Medical and Ethical Imperative: Equal Access to Cancer Care

Ensuring that cancer patients across Europe have equal access to the best possible cancer care, including early diagnosis, treatment and supportive care, is a medical and ethical imperative, Prof Martine Piccart (photo), the President of the European Society for Medical Oncology (ESMO), said at on Tuesday.

Speaking on the final day of the ESMO 2012 Congress in Vienna, which was attended by 16,402 persons from over 100…

Continue

Added by Peter Hofland, PhD on October 2, 2012 at 1:30pm — No Comments

ESMO 2012 Congress: Urgent Need for Integrated Oncology and Palliative Care

ESMO, the European Society for Medical Oncology, has awarded "ESMO Designated Center of Integrated Oncology and Palliative Care" accreditation to 16 new oncology centers. As part of the accreditation, the centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28…

Continue

Added by Peter Hofland, PhD on September 24, 2012 at 12:30pm — No Comments

ESMO 2012 Congress: Urgent Need for Integrated Oncology and Palliative Care

ESMO, the European Society for Medical Oncology, has awarded "ESMO Designated Center of Integrated Oncology and Palliative Care" accreditation to 16 new oncology centers. As part of the accreditation, the centers will receive the acknowledgment at the ESMO 2012 Congress, in Vienna, Austria, 28…

Continue

Added by Peter Hofland, PhD on September 24, 2012 at 12:30pm — No Comments

New Partnership Paves the Way for Major Leap Forward in Total Cancer Care

Social and emotional support are critical components of complete cancer care. Recognizing this fact, the Greenville Hospital System announced the partnership between the Center for Integrative Oncology and Survivorship, and the Cancer Support Community (CSC) – one of the largest worldwide providers of social and emotional support for cancer patients and their caregivers.



"Research shows that social and…

Continue

Added by Peter Hofland, PhD on June 26, 2012 at 2:00pm — No Comments

New Website and Mobile app Helps Physicians Locate Clinical Trials for Cancer Patients

A new searchable clinical trial mobile application for oncology healthcare professionals launched by Eli Lilly and Company allows healthcare professionals to search oncology trials that are enrolling new patients. The app searches by disease state, the molecule being studied, the study phase, country, state and keyword.



The app is available for …

Continue

Added by Peter Hofland, PhD on June 1, 2012 at 6:00pm — No Comments

Regorafenib Shows Statistically Significant Improvement in OS in Patients with mCRC Refractory to Standard Approved Therapies

The latest data on the investigational drug regorafenib (BAY 73-4506)from the Phase III CORRECT trial(Colorectal cancer treated with regorafenib or placebo after failure of standard therapy) were presented at the 2012 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI), in San Francisco, CA.



Regorafenib (BAY 73-4506) is an an investigational oral multi-kinase inhibitor developed by Bayer which targets angiogenic,…

Continue

Added by Peter Hofland, PhD on January 18, 2012 at 9:30am — No Comments

Rapid Growth of Palliative Care in Hospitals Continues for 10th Straight Year

For the tenth consecutive year palliative care in U.S. hospitals has increased for. A new analysis released today by the Center to Advance Palliative Care (CAPC) shows that the number of hospitals with a palliative care team increased from 658 (24.5%) to 1,568 (63.0%)– a steady 138.3% increase from 2000-2009.



Palliative care is specialized medical care focused on relief from the symptoms, pain and stress of… Continue

Added by Peter Hofland, PhD on July 14, 2011 at 7:30am — No Comments

Maintenance Therapy with Pemetrexed Shows Progression-Free Survival Benefit in Advanced Lung Cancer

A Phase III, randomized trial showed that maintenance therapy with the chemotherapy drug pemetrexed (Alimta®, Eli Lilly and Company) improves progression-free survival (PFS) in patients with advanced nonsquamous non-small cell lung cancer who also received pemetrexed as part of their initial chemotherapy regimen.



The data was prersented during the 47th annual meeting of the… Continue

Added by Peter Hofland, PhD on June 5, 2011 at 9:30am — No Comments

Caring for Cancer Survivors: PCP Reports More Concerns and Lack of Training than Medical Oncologist

The first national survey of barriers perceived by primary care physicians (PCPs) and medical oncologists (MOs) in the care of breast and colon cancer survivors showed that primary care doctors were significantly more likely than oncologists to report frequently ordering tests or treatments as malpractice protection.



They also more often reported being concerned about a lack of adequate training to manage breast and colorectal cancer survivors‟ health… Continue

Added by Peter Hofland, PhD on June 4, 2011 at 9:30am — No Comments

Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging

The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month at the National Institutes of Health (NIH). Dr. Marcela Bohm-Velez and her colleagues from Associates in Pittsburgh, Pa., shared preliminary results from a prospective study on low-dose MBI, specifically Breast-Specific Gamma Imaging (BSGI), at the SNM Breast Cancer Imaging: State of the Art 2011. Their results suggest it may be possible… Continue

Added by Peter Hofland, PhD on May 13, 2011 at 5:30am — No Comments

Roundtable Addresses the Many Faces and Challenges of Caregivers

A roundtable dedicated to the challenges that caregivers confront highlighted the need for honest information and emotional support at the National Comprehensive Cancer Network® (NCCN®) 16th Annual Conference. Sam Donaldson, ABC News veteran and cancer survivor, moderated a moving roundtable discussion between notable caregivers ranging from spouses, mothers, daughters, and clinicians.



Of the more than 1.3… Continue

Added by Peter Hofland, PhD on April 20, 2011 at 9:30pm — No Comments

Are Tanning Beds Safer Than Direct Sun?

Ignoring the warnings about tanning doesn’t keep you from suffering the consequences. “You couldn’t tell me anything, so I got in the tanning bed,” explains Brenda Sisson, a patient at the University of Alabama at Birmingham Cosmetic Dermatology Clinic, who couldn’t cut her daily tanning habit. And she’s not alone. The American Academy… Continue

Added by Peter Hofland, PhD on April 4, 2011 at 9:30pm — No Comments

Prolonging Quality of Life and Accessing Treatments for Late-stage Cancers are Issues of Growing Importance for Canadians

The Colorectal Cancer Association of Canada (CCAC), Canada's leading non-profit association dedicated to increasing awareness and education of colorectal cancer, supporting patients, and advocating for primary prevention, provincial screening programs as well as equal and timely access to effective treatments to improve patient outcomes earlier today announced findings from the Weighing Quality of Life in Cancer National Survey showing that an alarming 82% of Canadians have… Continue

Added by Peter Hofland, PhD on March 30, 2011 at 5:00am — No Comments

Patient Assistance Support Services Helps Thousands of Patients Afford Crucial High-quality Cancer Treatments

Through the continuous and tremendous growth of its patient assistance support program, US Oncology, Inc., a division of McKesson Corp. and a leading integrated oncology company, is helping cancer patients access the high quality cancer care they need. By helping patients obtain financial assistance, thousands can now afford much needed treatment and cancer therapies. The program is offered through practices affiliated with the United… Continue

Added by Peter Hofland, PhD on February 14, 2011 at 8:30am — No Comments

Skin Cancer Rising at Alarming Rate: Proper Sun Protection Helps Reduce Risk

For many young adults, the serious health consequences of tanning have been shown to have little impact on their behavior when it comes to sun exposure. But with spring break around the corner, dermatologists are urging people, particularly young adults, to practice proper sun protection and understand the importance of early detection of skin cancer, the most common type of cancer.



Speaking today at the 69th Annual Meeting of the…

Continue

Added by Peter Hofland, PhD on February 4, 2011 at 6:00am — No Comments

New Guide Helps Patients with Advanced Cancer Work with Physicians

Having advanced cancer is difficult for patients and their loved ones. But discussing the range of treatment options including palliative care with your doctor does not have to be. The American Society of Clinical Oncology (ASCO) has a new booklet to help patients with advanced cancer work with physicians to identify the best, individualized treatment plans.



The free booklet “Advanced Cancer Care Planning,”… Continue

Added by Peter Hofland, PhD on February 2, 2011 at 7:30pm — No Comments

National Comprehensive Cancer Network Develops New Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients

People with melanoma, ovarian cancer, or prostate cancer now have a new resource that provides them with the same credible information their physicians use when determining treatment options. The National Comprehensive Cancer Network (NCCN®) earlier today announced the addition of three new NCCN Guidelines for Patients™ to the library of patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™).



The new guidelines… Continue

Added by Peter Hofland, PhD on January 5, 2011 at 12:30am — No Comments

Understanding How New Health Care Reform Will Have Major Impact on Oncology Practice

Federal legislation on health care reform and coverage expansion is expected to have a major impact on healthcare and, especially, cancer care in the United States. The potential impact could be severe as some of the reforms will fundamentally change the way how the federal government pays for cancer care. Although the magnitude of proposed changes are not yet clear, community oncology professionals need to know how this legislation impacts them, their community practice and their… Continue

Added by Peter Hofland, PhD on December 24, 2009 at 8:00pm — No Comments

Monthly Archives

2013

2012

2011

2010

2009

2008

2007

2005

2004

2001

ADVERTISEMENT

Onco'Zine is present here

© 2013   Created by Peter Hofland, PhD.

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+